If Supply-Oriented Drug Policy is Broken, Can Harm Reduction Help Fix It?—Melding Disciplines and Methods to Advance International Drug Control Policy

Critics of the international drug control regime contend that supply-oriented policy interventions are not just ineffective, but they also produce unintended adverse consequences. Research suggests their claims have merit. Lasting local reductions in opium production are possible, albeit rare; but,...

Descripción completa

Guardado en:  
Detalles Bibliográficos
Autor principal: Letizia Paoli (Autor)
Otros Autores: Victoria A. Greenfield
Tipo de documento: Electrónico Libro
Lenguaje:Inglés
Acceso en línea: Volltext (kostenfrei)
Verificar disponibilidad: HBZ Gateway
Palabras clave:

MARC

LEADER 00000cam a22000002c 4500
001 1866334204
003 DE-627
005 20250207054833.0
007 cr uuu---uuuuu
008 231019nuuuuuuuuxx |||||o 00| ||eng c
035 |a (DE-627)1866334204 
035 |a (DE-599)KXP1866334204 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 2,1  |2 ssgn 
100 1 |a Letizia Paoli  |e VerfasserIn  |4 aut 
245 1 0 |a If Supply-Oriented Drug Policy is Broken, Can Harm Reduction Help Fix It?—Melding Disciplines and Methods to Advance International Drug Control Policy 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Critics of the international drug control regime contend that supply-oriented policy interventions are not just ineffective, but they also produce unintended adverse consequences. Research suggests their claims have merit. Lasting local reductions in opium production are possible, albeit rare; but, unless global demand shrinks, production will shift elsewhere, with little or no effect on the aggregate supply of heroin and, potentially, at some expense to exiting and newly emerging suppliers. The net consequences of the international drug control regime and related national policies are as yet unknown. In this paper, we consider whether “harm reduction,” a subject of intense debate in the demand-oriented drug policy community, can provide a unifying foundation for supply-oriented drug policy, one capable of speaking more directly to policy goals. Despite substantial conceptual and technical challenges, we find that harm reduction can provide a basis for assessing the net consequences of supply-oriented drug policy, choosing more rigorously among policy options, and identifying new policy options. In addition, we outline a practical path forward for assessing harms and policy options. 
650 4 |a Research 
700 1 |a Victoria A. Greenfield  |e VerfasserIn  |4 aut 
856 4 0 |u https://core.ac.uk/download/pdf/6644314.pdf  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mkri 
951 |a BO 
ELC |a 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4392979938 
LOK |0 003 DE-627 
LOK |0 004 1866334204 
LOK |0 005 20231019043710 
LOK |0 008 231019||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-2619)CORE2712298 
LOK |0 040   |a DE-2619  |c DE-627  |d DE-2619 
LOK |0 092   |o n 
LOK |0 852   |a DE-2619 
LOK |0 852 1  |9 00 
LOK |0 935   |a core 
OAS |a 1 
ORI |a SA-MARC-krimdoka001.raw